Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. (Q44028578)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. |
scientific article |
Statements
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab (English)
Martin Gunnarsson
Markus Axelsson
Peter Sundström
Charlotte Dahle
Magnus Vrethem
Tomas Olsson
Fredrik Piehl
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference